410 related articles for article (PubMed ID: 18403495)
1. Serum proteomic profiling of obese patients: correlation with liver pathology and evolution after bariatric surgery.
Trak-Smayra V; Dargere D; Noun R; Albuquerque M; Yaghi C; Gannagé-Yared MH; Bedossa P; Paradis V
Gut; 2009 Jun; 58(6):825-32. PubMed ID: 18403495
[TBL] [Abstract][Full Text] [Related]
2. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.
Liew PL; Lee WJ; Lee YC; Wang HH; Wang W; Lin YC
Obes Surg; 2006 Dec; 16(12):1584-93. PubMed ID: 17217634
[TBL] [Abstract][Full Text] [Related]
3. [Influence of bariatric surgery on the non-alcoholic liver steatosis. A histological evaluation].
Ferrer Márquez M; Carvia Pousaillè C; Velasco Albendea J; Rico Morales Mdel M; Casado Martín M; Belda Lozano R; Ferrer Ayza M
Cir Esp; 2009 Aug; 86(2):94-100. PubMed ID: 19560754
[TBL] [Abstract][Full Text] [Related]
4. Predictors of nonalcoholic steatohepatitis in patients undergoing bariatric surgery: when is liver biopsy indicated?
Helling TS; Helzberg JH; Nachnani JS; Gurram K
Surg Obes Relat Dis; 2008; 4(5):612-7. PubMed ID: 18226970
[TBL] [Abstract][Full Text] [Related]
5. [Relationship between morphological diagnosis of NASH (non-alcoholic steatohepatitis) and liver function tests in a group of patients with morbid obesity].
Chavarría-Arciniega S; López-Alvarenga JC; Uribe-Uribe NO; Herrera-Hernández M; González-Barranco J
Rev Invest Clin; 2005; 57(4):505-12. PubMed ID: 16315634
[TBL] [Abstract][Full Text] [Related]
6. Surgical treatment of non-alcoholic steatohepatitis and non-alcoholic fatty liver disease.
Weiner RA
Dig Dis; 2010; 28(1):274-9. PubMed ID: 20460923
[TBL] [Abstract][Full Text] [Related]
7. Hepatic histology in obese patients undergoing bariatric surgery.
Machado M; Marques-Vidal P; Cortez-Pinto H
J Hepatol; 2006 Oct; 45(4):600-6. PubMed ID: 16899321
[TBL] [Abstract][Full Text] [Related]
8. Duodenal switch has no detrimental effects on hepatic function and improves hepatic steatohepatitis after 6 months.
Keshishian A; Zahriya K; Willes EB
Obes Surg; 2005; 15(10):1418-23. PubMed ID: 16354521
[TBL] [Abstract][Full Text] [Related]
9. Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease.
Mathurin P; Hollebecque A; Arnalsteen L; Buob D; Leteurtre E; Caiazzo R; Pigeyre M; Verkindt H; Dharancy S; Louvet A; Romon M; Pattou F
Gastroenterology; 2009 Aug; 137(2):532-40. PubMed ID: 19409898
[TBL] [Abstract][Full Text] [Related]
10. Effects of bariatric surgery on nonalcoholic fatty liver disease: preliminary findings after 2 years.
Furuya CK; de Oliveira CP; de Mello ES; Faintuch J; Raskovski A; Matsuda M; Vezozzo DC; Halpern A; Garrido AB; Alves VA; Carrilho FJ
J Gastroenterol Hepatol; 2007 Apr; 22(4):510-4. PubMed ID: 17376042
[TBL] [Abstract][Full Text] [Related]
11. Histopathologic variability between the right and left lobes of the liver in morbidly obese patients undergoing Roux-en-Y bypass.
Larson SP; Bowers SP; Palekar NA; Ward JA; Pulcini JP; Harrison SA
Clin Gastroenterol Hepatol; 2007 Nov; 5(11):1329-32. PubMed ID: 17702661
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and predictive factors of non-alcoholic steatohepatitis (NASH) in morbidly obese patients undergoing bariatric surgery.
Harnois F; Msika S; Sabaté JM; Mechler C; Jouet P; Barge J; Coffin B
Obes Surg; 2006 Feb; 16(2):183-8. PubMed ID: 16469221
[TBL] [Abstract][Full Text] [Related]
13. Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients.
Ong JP; Elariny H; Collantes R; Younoszai A; Chandhoke V; Reines HD; Goodman Z; Younossi ZM
Obes Surg; 2005 Mar; 15(3):310-5. PubMed ID: 15826462
[TBL] [Abstract][Full Text] [Related]
14. Serum intercellular adhesion molecule-1 in patients with nonalcoholic steatohepatitis: comparison with alcoholic hepatitis.
Ito S; Yukawa T; Uetake S; Yamauchi M
Alcohol Clin Exp Res; 2007 Jan; 31(1 Suppl):S83-7. PubMed ID: 17331172
[TBL] [Abstract][Full Text] [Related]
15. Adipohormones as prognostric markers in patients with nonalcoholic steatohepatitis (NASH).
Krawczyk K; Szczesniak P; Kumor A; Jasinska A; Omulecka A; Pietruczuk M; Orszulak-Michalak D; Sporny S; Malecka-Panas E
J Physiol Pharmacol; 2009 Oct; 60 Suppl 3():71-5. PubMed ID: 19996485
[TBL] [Abstract][Full Text] [Related]
16. Apoptosis is associated with CD36/fatty acid translocase upregulation in non-alcoholic steatohepatitis.
Bechmann LP; Gieseler RK; Sowa JP; Kahraman A; Erhard J; Wedemeyer I; Emons B; Jochum C; Feldkamp T; Gerken G; Canbay A
Liver Int; 2010 Jul; 30(6):850-9. PubMed ID: 20408954
[TBL] [Abstract][Full Text] [Related]
17. Review article: Non-alcoholic fatty liver disease in morbidly obese patients and the effect of bariatric surgery.
De Ridder RJ; Schoon EJ; Smulders JF; van Hout GC; Stockbrügger RW; Koek GH
Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():195-201. PubMed ID: 18081662
[TBL] [Abstract][Full Text] [Related]
18. Serum adipokine levels in chronic liver diseases: association of resistin levels with fibrosis severity.
Tsochatzis E; Papatheodoridis GV; Hadziyannis E; Georgiou A; Kafiri G; Tiniakos DG; Manesis EK; Archimandritis AJ
Scand J Gastroenterol; 2008; 43(9):1128-36. PubMed ID: 18609175
[TBL] [Abstract][Full Text] [Related]
19. A genomic and proteomic study of the spectrum of nonalcoholic fatty liver disease.
Younossi ZM; Baranova A; Ziegler K; Del Giacco L; Schlauch K; Born TL; Elariny H; Gorreta F; VanMeter A; Younoszai A; Ong JP; Goodman Z; Chandhoke V
Hepatology; 2005 Sep; 42(3):665-74. PubMed ID: 16116632
[TBL] [Abstract][Full Text] [Related]
20. The importance of routine liver biopsy in diagnosing nonalcoholic steatohepatitis in bariatric patients.
Shalhub S; Parsee A; Gallagher SF; Haines KL; Willkomm C; Brantley SG; Pinkas H; Saff-Koche L; Murr MM
Obes Surg; 2004 Jan; 14(1):54-9. PubMed ID: 14980034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]